Army taps Vermillion for ovarian cancer Dx study

04/18/2013 | GenomeWeb Daily News (free registration)

The U.S. Army Medical Research and Materiel Command awarded Vermillion a contract to investigate the cost-benefits profile of the company's OVA1 test for ovarian cancer. The company will examine the assay's clinical use in managed care environments, and a multicenter clinical trial will evaluate the test as a presurgical standard of care in women who have pelvic masses.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX